Being an innovative company, ООО “NPK PHARMASOFT” is mainly focused on finding and development of new promising medications.

OOO “NPK PHARMASOFT” is the holder of intellectual proprietary right to the original drug Mexidol^® and a number of other medications. Considering the requirements of contemporary pharmaceutical market, the company systematically works on upgrading of its product range.

PHARMASOFT maintains permanent co-operation with the leading research and development enterprises, medications’ producers and hospitals of the Russian Federation and the CIS countries for the purpose of design of innovative drugs to open new trends of medicine. This also helps to thoroughly study the issues of safety, efficiency, as well as new features of the drugs already in use. Together with its partners, the company performs the full range of works aimed at the analysis of drugs, such as pharmaceutical design, study of analysis methods and production processes, pre-clinical and clinical trials.

All studies performed are in conformity with the effective Russian and international quality standards - GLP, GMP, GCP, GOST etc. The fact creates the necessary prerequisites for the development and introduction of modern original Russian medications to allow efficient treatment and prevention of widespread diseases, and improvement of patients’ lives quality.